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Abstract  
Background: This study replicates a previous postal survey of general practitioners 
(GPs) to explore whether attitudes to opioid prescribing have changed at a time when the 
number of opioid prescriptions issued in primary care has increased.  
Methods: With permission, a 57-item survey instrument previously utilised with GPs in 
the South-west of England was circulated to 214 GPs in city centre practices in the East 
Midlands. The survey instrument included items relating to practice context, prescribing 
patterns and attitudes about analgesic medication, perceived prescribing frequency and 
reluctance to prescribe.  
Results: Responses were received from 94 GPs (45%). Almost three-quarters (72.7%) of 
GPs reported that they sometimes or frequently prescribed strong opioids for chronic 
non-cancer pain. Over two-thirds (67.8%) reported that they were sometimes or 
frequently reluctant to prescribe strong opioids for chronic non-cancer pain. No 
significant relationships were observed between perceived frequency of prescribing and a 
range of demographic factors; however, concerns about ‘physical dependence’, ‘long-
term commitment to prescribing’ and ‘media reports’ were associated with less frequent 
reported prescribing of, and greater reluctance to prescribe, strong opioids.  
Discussion: Given the national trend for increased opioid prescriptions, it is unsurprising 
that more frequent self-reported prescribing is reported here; however, increased 
frequency does not translate into less reluctance about prescribing. The effectiveness of 
strong opioids for chronic pain is recognised, but concerns about addiction, dependence 
and misuse inform a reluctance to use strong opioids. These juxtapositions highlight a 
continued need for clearer understanding of GPs’ perceptions of strong opioids and point 
to the potential benefit of dedicated guidelines or specialist education and training to 
address their uncertainties. 
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Introduction 
Chronic non-cancer pain (CNCP) is a widespread health problem which affects around 
7.8 million people in the United Kingdom.1 Its aetiology may be degenerative, neuralgic, 
post-surgical or simply unknown; it is most common among those over 50years, but it 
may affect all age groups from school children to the most elderly.2 The implications for 
patients experiencing CNCP can be long term; for one-third of sufferers, it is a lifelong 
condition,1 and wide-reaching, with potential impact upon employment, mental health 
and lifestyle.3 The economic impact of CNCP is considerable: in 2010, the total cost of 
controlled medication prescribed in National Health Service (NHS) primary care was 
£455,013,758, and the vast majority of these were opioid drugs;4 in 2007, back pain cost 
the UK economy £12.3 billion, and chronic pain is the second most common reason for 
claiming incapacity benefit.3 
CNCP is a condition which is difficult to manage; 68% of chronic pain sufferers describe 
times when their pain is not adequately controlled,3 and the quality of long-term pain 
management is often poor.2 Survey research shows that 81% of general practitioners 
(GPs) felt patients received suboptimal pain management with effective control in less 
than half of the cases.5 Analgesic medications are prescribed commonly, and, for 
carefully selected patients, strong opioids such as morphine sulphate, oxycodone, 
fentanyl and buprenorphine may play a role in the management of CNCP.6 CNCP is 
commonly managed in primary care settings, and it has been shown that the use of strong 
opioids can generate significant uncertainty for both GPs and patients.7–9 Patients are 
commonly concerned about physical dependence, tolerance and addiction.7,9 GPs share 
some of these concerns, and comment in both academic journals10–14 and the popular 
press15–17 illustrates the continued controversy about the use of opioids in the 
management of CNCP; to borrow from Stannard11 the debate has seemingly turned from 
‘why not prescribe opioids?’ to ‘why not to prescribe opioids’. 
Despite this, a greater number of opioid prescriptions are being issued4,18 – between 
2007 and 2010, primary care prescriptions of the four main strong opioids increased from 
4.2 to 5 million.4 Guidelines to support the prescription of opioids19 and changes to the 
medical school curriculum (to include pain management) may be pertinent in this trend; 
new formulations of opioid drugs and their promotion by the pharmaceutical industry 
may also be a factor. Whichever, it is clear that the context of opioid prescribing in 
general practice is complex. 
Previous works by McCracken et al.7,8 and Hutchinson et al.9 have attempted to shed 
light upon this by consid-ering GPs’ prescribing patterns and their attitudes towards 
opioid medication. Both studies demonstrate a complex relationship between GP 
demographics, GP attitudes and GP prescribing practice; both studies highlight that 
significant numbers of GPs do not pre- scribe opioids/strong opioids (25%/42%). 
Although limited in scope, these studies suggest that younger GPs, male GPs and GPs in 
full-time practice are more likely to prescribe opioids.  
 
 
Formal training was seen to impact positively upon opioid prescribing, although use of 
formal guidelines did not.8 Unsurprisingly, those less concerned about the use of opioid 
drugs and those who view them as appropriate for CNCP also prescribe them more 
frequently.8 
Previous research has highlighted an uncertainty about opioid prescription which persists; 
for GPs, this includes concerns about professional competency (through a lack of training 
and prescribing guidelines), concerns relating to patient behaviour (such as addiction and 
the need for long-term commitment) and concerns about the risk of strong opioids; for 
patients, concerns may include addiction, perceptions of others and experience of side 
effects.7–14 There is a growing concern about the use of opioids (alongside their 
increased use) which indicates the need for further research to uncover and understand 
prescribing patterns. This study builds upon the work previously undertaken by 
McCracken et al.7,8 by (1) exploring whether attitudes to opioid prescribing have 
changed over time, given increases in the number of opioid prescriptions issued in 
primary care and (2) exploring changes in attitudes and patterns of prescribing with a 
different demographic and socio-economic profile of GPs since previous research had a 
limited geographic scope. 
Methods 
Sample selection 
Using the NHS choices website,20 all GPs in NHS Nottingham City Primary Care Trust 
region were identified. At the time of the study, NHS Nottingham City Primary 
CareTrust (PCT) provided healthcare to a population of approximately 350,000 people 
including 62 medical practices with 214 GPs (NHS Nottingham City Clinical 
Commissioning Group is now responsible for commissioning healthcare in this region). 
Nottingham City is part of a larger urban conurbation (population is excess of 600,000) 
and is a city marked by significant deprivation; a quarter of the city’s population reside in 
areas in the most 10% deprived in England. It is an ethnically diverse city with 25% 
residents from Black or minority ethnic groups. Health inequalities are prominent and life 
expectancy lags behind the national average; in the most disadvantaged parts of the city 
men live on average 9.2 years fewer than the national average and women 8 years 
fewer.21 
Questionnaire development 
The questionnaire was developed by McCracken et al.8 to investigate patterns of 
prescription and concern about opioid analgesics for chronic non-malignant pain in 
general practice in the South West of England. It was informed by both literature review 
and the clinical practice of the original research team (GPs and psychologists with 
extensive clinical experience of chronic pain management). It is used here with per- 
mission and without alteration to enable direct comparison of data across regions and at 
different times. 
The survey was a 57-item instrument designed to gather data regarding GPs, the situation 
of their practice, perceived patterns of prescribing analgesic medications, their concerns 
and attitudes about analgesic medications. It was organised into three sections: (1) 
Questions about yourself and your practice, (2) Treating chronic pain at your practice, 
and (2) Your prescribing of analgesic medications for chronic pain. Self-reported 
frequency of prescribing ‘strong opioids’, ‘weak opioids’, ‘non-steroidal anti-
inflammatory drugs (NSAIDs)’ and other drugs for chronic non-malignant pain was 
measured on a Likert-type scale with responses including ‘always’, ‘frequently’, 
‘sometimes’, ‘rarely’, ‘never’ or ‘unsure’. Reluctance to prescribe opioid analgesics for 
chronic non-malignant pain, cancer pain and acute pain was measured using the same 
scale. Attitudes and beliefs about prescribing opioid analgesic were considered in a 
number of ways across the instrument including questions relating to perceptions of 
appropriateness, effectiveness, social pressure and adverse effects. A total of 15 key 
‘rationally derived attitude and belief items’8 were rated on a five point scale (Figure 1) 
with responses ‘often true’, ‘almost always true’ or ‘always true’ taken to indicate the 
respondents’ endorsement of the statement. 
Study protocol and data collection 
Correspondence with the local ethics committee established that formal ethical approval 
was not required for this study; local research governance procedures for the relevant 
region were followed. In February 2011, a questionnaire survey and postage-paid reply 
envelope were mailed to 214 GPs from 62 practices in Nottingham City together with a 
covering letter providing information about the study. Two follow-up reminders were 
posted to non-responders at 3-week intervals, and informed consent was taken to be 
return of the form. Four replies indicated that GPs no longer practised in the region, and 
completed questionnaires were received from 94 GPs, giving an overall response rate of 
45%. 
Analysis 
Data were handled using SPSS PAS-W version 19.0. Analysis included descriptive 
statistics, chi-square test and Wilcoxon’s signed-rank test. 
Figure 1. Percentage of general practitioners endorsing each survey item regarding 
attitudes and concerns about strong opioids as ‘often’, ‘almost always’ or ‘always true’ 
(N = 91). 
 
 




Of those who responded, 38% were male (n = 36) and 53% female (n = 50; eight did not 
report their gender); age ranged from 29.3 to 69.5 years (n = 82, mean = 48.6 years, 
standard deviation (SD) = 9.6 years); 95% worked in urban areas and 5% in mixed urban/ 
rural areas. The majority of respondents (85%, n = 73) obtained their primary medical 
qualification in the United Kingdom, with the remainder obtaining their qualification 
elsewhere (15%, n = 13). Over two-thirds of respondents described themselves as White 
(69%), with the remainder describing themselves as Indian (17%), Pakistani (5%), Black 
African (1%), other Asian (1%) or other (7%). Respondents reported having spent 
between 1 and 34 years working in general practice (mean years = 17, SD = 8). 
Treating chronic pain 
Only 11% of GPs reported completing some type of specialty training in chronic pain 
management; this included courses on medicines, palliative care and general pain 
management. 
Excluding analgesic medication, acupuncture (25%, n = 23) was the most frequently 
reported treatment offered, with no other complementary therapies reported. Of the 
conventional therapies, 20% (n = 18), 15% (n = 14) and 12% (n = 11) of GPs indicated 
that they provided counselling, physiotherapy and psychological treatments within their 
practice, respectively. Just 22% of respondents (n = 20) reported they had a defined 
protocol or care pathway for referral of patients to secondary care chronic pain 
management services. 
Of the GPs, 60% reported that they sometimes prescribed strong opioids for chronic non-
malignant pain, 27% reported rarely and 13% reported frequently. Reported prescribing 
of strong opioids was less frequent than reported prescribing of other analgesic 
medications (Figure 2): Wilcoxon’s matched-pairs signed-rank tests showed that these 
frequency ratings differed significantly from the ratings for the reported prescription of 
weak opioids (Z = −7.34, p < 0.001), NSAIDs (Z = −6.30, p < 0.001) and tricyclic 
antidepressants (Z = −7.30, p < 0.001). 
More than half of the GPs (53%) reported they were sometimes reluctant to prescribe 
strong opioids for CNCP, 24% reported rarely, 16% frequently, 4% never and 3% always 
reluctant to prescribe. Greater reluctance was reported in the use of strong opioids for 
CNCP than for use in cancer pain (Figure 3): Wilcoxon tests showed that these reluctance 
ratings were significantly different from those for cancer pain (Z=−8.07, p<0.001), but  
not different from those for acute pain (Z = −0.25, p = 0.98). 
More than half of the respondents (57%) reported that they followed guidelines or 
recommendations for the prescribing of medication for chronic pain; just under half 
(43%) reported either that they did not follow guidelines (27%) or that they were unsure 
(16%). Of the 57% who reported following guide- lines, only a minority of GPs indicated 
which ones they used and these varied. Where reported, the National Institute for Clinical 
Excellence (NICE) guideline was the most commonly identified, followed by the World 
Health Organization guidelines and then the British National Formulary (BMF). Also 
cited were hospital guidelines, local Primary Care Trust guidelines, hospice guidelines 
and the Bandolier Pain Ladder. 
GP and practice characteristics associated with strong opioid prescription for chronic 
pain 
Analyses were conducted to examine potential correlates of perceived frequency of 
prescribing. Spearman’s correlation coefficients showed that there was no significant 
relationship between perceived frequency of prescribing and GP age, years in practice, 
number of GPs in the practice, approximate patient list size or practice location. Those 
who reported a greater reluctance to prescribe in turn reported prescribing less frequently 
(p < 0.001). Chi-square tests showed that there was no relationship between gender and 
perceived frequency of prescribing. 
 
Figure 2. Survey results demonstrating percentages of general practitioners prescribing 
four common classes of analgesic medications for chronic non-malignant pain (N = 91). 
NSAIDS: non-steroidal anti-inflammatory drugs. 
 Figure 3. Survey results demonstrating percentages of general practitioners reporting 
reluctance to prescribe strong opioids for non-malignant pain, cancer pain and acute pain 
(N = 91). 
 
There were no significant differences in the perceived frequency of prescribing between 
GPs who were full-time and those who were part-time, ✗2 (2, N=88)=0.57, p=0.75. In 
this sample, GPs who had specialty training did not differ significantly in their perceived 
frequency of prescribing from those who had not,  ✗2 (2,N=87)=2.33,p=0.31. The use of 
practice guidelines was unrelated to perceived frequency of prescribing, 
✗2(4,N=84)=1.02, p=0.90. 
GP and practice characteristics associated with reluctance to prescribe opioids 
Analyses were conducted to examine potential correlates of reluctance to prescribe strong 
opioids. As with the perceived frequency of prescribing data, ratings of reluctance were 
unrelated to GP gender, ✗2 (4, N = 85) = 5.56, p = 0.24. Work hours (part-time or full- 
time) was unrelated to reluctance to prescribe, ✗2 (4, N = 90) = 2.97, p = 0.56. GPs who 
had specialty training did not differ in their level of reluctance from those who had not 
had any training, ✗2 (4, N = 89) = 3.24, p = 0.58. The use of practice guidelines was 
unrelated to reluctance to prescribe strong opioids, ✗2 (8, N = 86) = 8.38, p = 0.40, as 
was practice location, ✗2 (4, N=88)=6.19, p=0.19. 
 
GP attitudes and beliefs 
Most GPs believed that opioids are effective for chronic pain (79%). A total of 80% felt 
sufficiently trained in the prescription of opioids. Three-quarters of respondents 
expressed concerns about addiction (76%) and physical dependence (73%). Two-thirds 
(66%) reported reluctance to prescribe when a clear diagnosis was absent. Almost two-
thirds were worried about patients experiencing sedation and confusion (65%), and 38% 
were concerned about patients experiencing impaired thinking. Over half (58%) reported 
seeing no option but to prescribe opioids for some patients. Just under half of the GPs 
expressed concerns about medical misuse (47%), medical diversion (40%) and harm- ing 
patients (43%). In all, 62% were concerned about a long-term commitment to prescribing 
opioids and 29% were worried about professional scrutiny. Around one-fifth (22%) 
reported they found media coverage of cases of inappropriate opioid use discouraging. 
More than one in five GPs (21%) indicated they lacked confidence in the area of 
prescribing analgesics. 
Associations between GP attitudes and beliefs, and opioid prescribing 
The associations between the 15 GP attitudes and concerns and the GPs’ frequency of 
prescribing and reluctance to prescribe strong opioid analgesics for chronic non-
malignant pain were examined (Table 1). 
Only 3 of the 15 attitude and concern items were significantly correlated with perceived 
frequency of prescribing opioids at a Bonferroni-corrected α level of p<0.003 (0.05/15). 
These three correlates are ‘concern about a long-term commitment to prescribing 
opioids’, ‘worry about physical dependence’ and ‘discouraged by media accounts’. The 
higher the GPs’ levels of concern about long-term commitment and worry about patients 
becoming physically dependent, and the more discouraged about media accounts of 
medical misuse of opioids, the less frequently they reported prescribing strong opioids. 
The correlation results demonstrate that the attitude and concern items were more highly 
associated with the reluctance ratings than the perceived frequency of prescribing. Of the 
15 attitude and concern items, 9 achieved significant correlations with reluctance to 
prescribe strong opioids, 6 of which reached p<0.001 level. The strongest correlate was 
‘concern about a long-term commitment to prescribing strong opioids’, followed by 
‘concern about addiction’ and ‘reluctance to prescribe without a diagnosis’. GPs who 
reported these concerns to a greater degree were more reluctant to prescribe opioids. 
Degree of feeling sufficiently trained to prescribe opioids and a worry about harming 
patients were both moderately sized but significant predictors of reluctance to prescribe. 
When the GPs felt they were sufficiently trained and were less worried about harming 
patients, they were less reluctant to prescribe. 
Other weaker but significant predictors were ‘worry about physical dependence’, ‘opioids 
are effective for chronic pain’, ‘discouraged by media accounts’ and ‘worry about 
impaired thinking’. When the GPs were more concerned about patients becoming 
physically dependent on opioids and about opioids impairing patients’ thinking, they 
were more reluctant to prescribe opioids. Also, when they were more discouraged by the 
media accounts of medical misuse of opioids, they were more reluctant to prescribe. 
When GPs felt that opioids were effective for treating chronic pain, they were less 
reluctant to prescribe. 
 
Discussion 
This work marks a timely repeat of McCracken et al.’s8 previous review of GP 
prescribing and attitudes towards strong opioid medication. Conducted at a time when 
opioid prescriptions are on the increase in the United Kingdom,4,22 when campaigning 
organisations are calling for improved management of CNCP1,23 and when media 
reports highlight concern about strong opioid drugs,15–17 this study provides pertinent 
insight into an important and contentious topic. 
Given the nationwide trend for increased willingness to prescribe opioids for chronic 
pain,24 perhaps fuelled by aggressive pharmaceutical marketing,25 it is unsurprising that 
GPs here reported more frequent prescribing of opioids for CNCP. Almost three-quarters 
of our sample reported that they sometimes or frequently prescribed opioids for CNCP, 
and no GP never prescribes; in the previous study, more than 4 in 10 reported that they 
rarely or never prescribed. Previous demographic differences in prescribing patterns 
appear to have diminished and we found no difference in the perceived prescribing 
frequencies of male and female GPs, full- and part-time GPs, and older and younger GPs. 
GPs who are less reluctant about prescribing opioids do report prescribing more 
frequently, but overall prescribing appears to be greater in recent years with no clear 
demographic trends. More GPs reported accessing prescribing guidelines (57% compared 
with 43%), although it should be noted that the most frequently cited26 is for neuropathic 
pain which contains little information on opioids; more specific guidelines from the 
British Pain Society19 and Royal College of Anaesthetists were not identified here. Only 
1 in 10 of our GPs had received formal training in pain management (comparable with 
the earlier study), and neither formal training nor guideline use was related to perceived 
frequency of prescribing in our study. 
While our sample suggests marked changes in the frequency of reported prescribing a 
reported reluctance to prescribe persists. In both studies approximately half of GPs 
described being sometimes reluctant to prescribe opioids and around one in five always 
or frequently reluctant. As with McCracken et al.’s8 previous study reluctance to 
prescribe is more strongly correlated to GP attitudes and concerns than perceived 
frequency of prescribing. Across both studies, a number of concerns and attitudes are 
consistently related to a reluctance to prescribe – concerns about addiction, about 
commitment in the long-term and about prescribing without diagnoses being the strongest 
and most consistent across the two studies. Concerns about addiction and physical 
dependence are stronger in our sample, and almost twice as many GPs are now concerned 
about opioids being diverted for non-medicinal use by others, compared with the 
previous survey.8 This finding is not unexpected given the media attention in recent years 
surrounding the ‘prescription opioid crisis’ – prescription drug misuse and dependence, 
coupled with steep increases in opioid-related mortality.27 
Despite these concerns, most GPs feel that opioids are effective in cases of CNCP. In our 
sample, more GPs feel sufficiently trained to prescribe opioids and there is less reluctance 
to prescribe without diagnosis. Each of these attitudes is inversely correlated with 
reluctance to prescribe, but none are significantly related to reported frequency of 
prescription. Relationships between perceived prescribing frequency and GP attitudes and 
concerns are weaker in our study than the previous work with one notable exception. 
Here, feeling discouraged by media accounts demonstrates a stronger correlation with 
reduced prescribing than in the earlier study (it is also significantly correlated to 
increased reluctance to prescribe). The impact of the media may be important in 
understanding why the reluctance to prescribe opioids has not diminished at a time when 
the number of opioid prescriptions has increased. 
There are other factors that may influence GPs’ prescribing patterns, such as lack of 
pharmacological alternatives and a lack of concrete guidelines to inform opioid use. 
Continued uncertainty about opioids might suggest that GPs prescribe despite their 
concerns and not because of a commitment to their use. More than half of the GPs 
surveyed here indicated that they often perceive no alternative but to prescribe opioid 
medication, and only four non-pharmacological treatment alternatives were proposed by 
GPs in this survey, each available in only small number of practices. This is consistent 
with previous findings8 and indicates that while the number of formulations of opioids 
may be increasing, the use of alternative therapies and non- pharmacological pain 
management strategies is not. Continued uncertainty in managing opioid prescriptions 
may also stem from a lack of clear formal support and guidelines. Few GPs in our sample 
reported having received formal training, few adhered to a formal pathway for treating 
CNCP and most of those who utilised guidelines referred to NICE guidelines, which are 
of limited application in the management of opioid prescriptions. It may be relevant that, 
at the time of data collection, pain management lay outside the Quality and Outcomes 
(QOF) Framework for General Medical Services; inclusion of pain management in such a 
framework might generate greater scrutiny, more clarity and more consistency in opioid 
prescribing and management. In summary, therefore, it appears that changes in perceived 
prescribing frequency have not been matched by changes in prescribing support for GPs; 
this might be addressed through (1) inclusion of pain management in QOF,1 (2) 
advocating the provision, use and adoption of ‘good practice’ guidelines for opioid 
prescription and (3) enhanced and increased provision of pain management education and 
training. The need for increased training and support for GPs regarding opioid 
prescribing is now being recognised, and it has been suggested that training and 
education are acceptable to GPs and may increase knowledge about opioids and reduce 
concerns about prescribing, but does not appear to influence prescribing behaviour or GP 
well-being (related to prescribing).28 
The findings of this study are limited to retrospective reports of prescribing practices, 
rather than objective observations of prescribing behaviour. Our response rate was 
relatively low and we do not have data on non-responders. However, low response rates 
are a common challenge in research with GPs; our response rate was greater than that of 
McCracken et al.,8 and previous studies have had comparable response rates without 
showing evidence of responder bias.29 
Conclusion 
Despite changes to the context of opioid prescribing in the United Kingdom, the findings 
of this survey are similar to those of previous studies that have attempted to shed light on 
GP experiences and attitudes towards opioid prescribing for CNCP.8,9 The frequency of 
prescribing has increased, but concerns about opioid use and a reluctance to prescribe 
persist for many GPs, and importantly persist for GPs with varying levels of prior 
training and experience and from diverse demographics. This juxtaposition points to the 
continued need for greater clarity in our understanding of how GPs perceive the benefits 
and challenges of opioid use. It also points to an ongoing need for more explicit guidance 
in the process of opioid prescribing – guidelines such as those generated for the 
management of opioids in palliative care30 would be a positive step forward. Additional 
training and educational provision in pain management and in the management of opioid 
prescriptions may be required to support GPs to feel more confident in their prescribing. 
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